Streptokinase is more economical than alteplaseBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1506 (Published 02 December 1995) Cite this as: BMJ 1995;311:1506
- J C Mucklow, Senior lecturer (clinical pharmacology)
- Department of Pharmacy Policy and Practice, Keele University, Keele ST5 5BG
EDITOR,--Marc Verstraete cites streptokinase and alteplase as alternative thrombolytic drugs for the management of myocardial infarction.1 His guidance on choice is confined to the statement that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial